<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03257280</url>
  </required_header>
  <id_info>
    <org_study_id>DOPGT_2015</org_study_id>
    <nct_id>NCT03257280</nct_id>
  </id_info>
  <brief_title>Trial on Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Patients After Total Gastrectomy. (DOPGT_2015)</brief_title>
  <official_title>Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Gastric Cancer Patients After Total Gastrectomy: A Prospective Randomized Control Trial (DOPGT_2015)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitari de Bellvitge</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitari de Bellvitge</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized controlled clinical trial to clarify the effect of early
      oral nutrition introduction after total gastrectomy in gastric cancer patients on the length
      of hospital stay, comparing an experimental group vs control group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The total gastrectomy is a high complexity surgery that involves a high morbid-mortality. In
      our center, the postoperative management consisted in 1 week period of non oral intake and
      total parenteral nutrition. At the 7 day, an oral contrast image is performed to prove the
      correct function of the anastomosis, in witch case, a progressive oral diet is begin.

      In the late 90s, the Fast-track concept (or multimodal perioperative patient care) was
      introduced in the surgical patients attempting to improve their postoperative course. This
      new concept includes the preoperative advices related to the surgery, the intensive
      mobilization after surgery, the early oral diet, and to avoid the routinary use of the
      nasogastric tube. Some groups have been trying to apply this Fast-track program sporadically
      in patients submitted to an elective total gastrectomy for gastric cancer, even do, there is
      still no good evidence to sport these practice.

      Based on the reasons exposed before, the investigators design a prospective randomized
      controlled trial in gastric cancer patients underwent on a total gastrectomy comparing two
      groups. 24 hours after gastrectomy the investigators will administer oral methylene blue and
      if no evidence of drainage leakage the participants will be randomized into two groups: one
      of them with our classical postoperative management, and the other one implements an early
      oral nutrition protocol, having in considerations its effectiveness, security, and impact on
      the hospital stay.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2017</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>postoperative 1 day to discharge, up to 1 month after surgery</time_frame>
    <description>Postoperatory hospital stay in days</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>During the admission, two weeks and one month after surgery</time_frame>
    <description>Postoperative Mortality: Deaths occurring during admission and / or within 30 days after surgery or during surgical admission if it lasts longer than 30 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital readmissions</measure>
    <time_frame>Two weeks and one month after surgery</time_frame>
    <description>It will be considered the income produced within 30 days after the surgical intervention in which the cause of the admission is attributed to a complication in relation to the surgical intervention.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>First day of hospital admission, two weeks and one month after surgery</time_frame>
    <description>weight shall be measured in kilograms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anastomotic dehiscence</measure>
    <time_frame>postoperative 1 day to discharge, up to 1 month after surgery</time_frame>
    <description>Anastomotic dehiscence: If the intra-abdominal drainage presents a purulent appearance or an amylase determination&gt; 30, suspicion of anastomosis dehiscence will be made; In this situation, a clinical test (intake of methylene blue) radiological test (with oral contrast) or endoscopy will be requested to confirm the diagnosis. Anastomosis dehiscence will be confirmed if any of the following occurs:
Exit of methylene blue through intra-abdominal drainage
Contrast leakage in a radiological test performed for sepsis
Evidence of dehiscence in a fibrogastroscopy
Evidence of anastomotic dehiscence during a reintervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duodenal stump leak</measure>
    <time_frame>postoperative 1 day to discharge, up to 1 month after surgery</time_frame>
    <description>Intra-abdominal drainage presents a purulent appearance with amylase determination&gt; 30 and a bilirubin value higher than plasmatic bilirubin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Paralytic ileus</measure>
    <time_frame>postoperative 1 day to discharge, up to 1 month after surgery</time_frame>
    <description>When three of the following criteria are met.
Oral intolerance after the fourth postoperative day Abdominal distention and tympanism No bowel motions or flatus Compatible abdominal x-ray</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-Abdominal abscesses</measure>
    <time_frame>postoperative 1 day to discharge, up to 1 month after surgery</time_frame>
    <description>Radiological criteria:
Air inside the collection Collection with heterogeneous and irregular pickup or wall pickup Collection with heterogeneous content
Isolation of one or more microorganisms in culture after percutaneous collection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Hemoperitoneum</measure>
    <time_frame>postoperative 1 day to discharge, up to 1 month after surgery</time_frame>
    <description>Presence of blood in the abdominal cavity after gastrectomy that needs any kind of treatments</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evisceration</measure>
    <time_frame>postoperative 1 day to discharge, up to 1 month after surgery</time_frame>
    <description>Extrusion of viscera outside the body through a surgical incision</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Superficial Incisional Surgical Site Infection</measure>
    <time_frame>postoperative 1 day to discharge, up to 1 month after surgery</time_frame>
    <description>Superficial Incisional Surgical Site Infection
Infection within 30 days after the operation and only involves skin and subcutaneous tissue of the incision and at least one of the following:
Purulent drainage with or without laboratory confirmation, from the superficial incision.
Organisms isolated from an aseptically obtained culture of fluid or tissue from the superficial incision.
At least one of the following signs or symptoms of infection: pain or tenderness, localised swelling, redness, or heat and superficial incision is deliberately opened by surgeon, unless incision is culture-negative.
Diagnosis of superficial incisional surgical site infection made by a surgeon or attending physician.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Height</measure>
    <time_frame>First day of hospital admission, two weeks and one month after surgery</time_frame>
    <description>Height shall be measured in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of weight lost</measure>
    <time_frame>First day of hospital admission, two weeks and one month after surgery</time_frame>
    <description>Percentage of weight lost shall be measured in percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impedancemetry</measure>
    <time_frame>First day of hospital admission, two weeks and one month after surgery</time_frame>
    <description>The impedanciometry will record:
Phase-angle Na / K ratio Basal metabolism (Kcal) Fat mass percentage Muscle mass percentage Cell mass percentage Extracellular mass percentage</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Early Oral Nutrition After Total Gastrectomy</condition>
  <condition>Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Early oral nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An early oral nutrition with supplements and increased progressively according to an established schedule, start 48 hours after total gastrectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In our center, the classical postoperative management consisted in one week period of non oral intake and total parenteral nutrition. At the 7 day, an oral contrast image is performed to prove the correct function of the anastomosis, in witch case, a three days progressive oral diet is begin.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Early oral nutrition</intervention_name>
    <description>An early oral nutrition with supplements and increased progressively according to an established schedule, start 48 hours after total gastrectomy.</description>
    <arm_group_label>Early oral nutrition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients requiring radical total gastrectomy for gastric cancer.

          -  18 or above years old.

          -  Acceptance and signing the full informed consent.

        Exclusion Criteria:

          -  Patient with poorly controlled diabetes mellitus (glycosylated hemoglobin levels
             greater than 7%)

          -  Emergency surgery.

          -  Total gastrectomy with esophagus-jejunal manual suture.

          -  Early dehiscence of esophagus-jejunal anastomosis (first 24 hours).

          -  Reintervention for abdominal complication in the first 24 hours.

          -  Surgery involving large intestinal or colon resections.

          -  Proximal resection margin affected requiring a esophagectomy and reconstruction with
             coloplasty.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leandre Farran Teixidor, PhD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bellvitge University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leandre Farran Teixidor, PhD, MD</last_name>
    <phone>+34-93-335-90-11</phone>
    <phone_ext>2316</phone_ext>
    <email>lfarran@bellvitgehospital.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fernando Estremiana Garcia, MD</last_name>
    <phone>+34-93-335-90-11</phone>
    <phone_ext>2316</phone_ext>
    <email>festremiana@bellvitgehospital.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Leandre Farran Teixidor</name>
      <address>
        <city>L'Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leandre Farran Teixidor, PhD, MD</last_name>
      <phone>+34-93-335-90-11</phone>
      <phone_ext>2316</phone_ext>
      <email>lfarran@bellvitgehospital.cat</email>
    </contact>
    <contact_backup>
      <last_name>Fernando Estremiana Garcia, MD</last_name>
      <phone>+34-93-335-90-11</phone>
      <phone_ext>2316</phone_ext>
      <email>festremiana@bellvitgehospital.cat</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>González CA, Agudo A. Carcinogenesis, prevention and early detection of gastric cancer: where we are and where we should go. Int J Cancer. 2012 Feb 15;130(4):745-53. doi: 10.1002/ijc.26430. Epub 2011 Oct 20. Review.</citation>
    <PMID>21918974</PMID>
  </reference>
  <reference>
    <citation>Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R; Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011 Nov;60(11):1449-72. doi: 10.1136/gut.2010.228254. Epub 2011 Jun 24. Review.</citation>
    <PMID>21705456</PMID>
  </reference>
  <reference>
    <citation>Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M, Glynne-Jones R, Grothey A, Haller D, Haustermans K, Kerr D, Nordlinger B, Marshall J, Minsky BD, Kang YK, Labianca R, Lordick F, Ohtsu A, Pavlidis N, Roth A, Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Van de Velde C, Zalcberg J. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol. 2011 Jun;22 Suppl 5:v1-9. doi: 10.1093/annonc/mdr284.</citation>
    <PMID>21633049</PMID>
  </reference>
  <reference>
    <citation>Viudez-Berral A, Miranda-Murua C, Arias-de-la-Vega F, Hernández-García I, Artajona-Rosino A, Díaz-de-Liaño Á, Vera-García R. Current management of gastric cancer. Rev Esp Enferm Dig. 2012 Mar;104(3):134-41. Review.</citation>
    <PMID>22449155</PMID>
  </reference>
  <reference>
    <citation>Okines A, Verheij M, Allum W, Cunningham D, Cervantes A; ESMO Guidelines Working Group. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010 May;21 Suppl 5:v50-4. doi: 10.1093/annonc/mdq164.</citation>
    <PMID>20555102</PMID>
  </reference>
  <reference>
    <citation>Wong J, Kelly KJ, Mittra A, Gonen M, Allen P, Fong Y, Coit D. Rt-PCR increases detection of submicroscopic peritoneal metastases in gastric cancer and has prognostic significance. J Gastrointest Surg. 2012 May;16(5):889-96; discussion 896. doi: 10.1007/s11605-012-1845-2. Epub 2012 Feb 24.</citation>
    <PMID>22362071</PMID>
  </reference>
  <reference>
    <citation>Takata A, Kurokawa Y, Fujiwara Y, Nakamura Y, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Mori M, Doki Y. Prognostic value of CEA and CK20 mRNA in the peritoneal lavage fluid of patients undergoing curative surgery for gastric cancer. World J Surg. 2014 May;38(5):1107-11. doi: 10.1007/s00268-013-2385-y.</citation>
    <PMID>24305936</PMID>
  </reference>
  <reference>
    <citation>Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010 Dec;17(12):3077-9. doi: 10.1245/s10434-010-1362-z.</citation>
    <PMID>20882416</PMID>
  </reference>
  <reference>
    <citation>Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011 Jun;14(2):113-23. doi: 10.1007/s10120-011-0042-4.</citation>
    <PMID>21573742</PMID>
  </reference>
  <reference>
    <citation>Feng F, Ji G, Li JP, Li XH, Shi H, Zhao ZW, Wu GS, Liu XN, Zhao QC. Fast-track surgery could improve postoperative recovery in radical total gastrectomy patients. World J Gastroenterol. 2013 Jun 21;19(23):3642-8. doi: 10.3748/wjg.v19.i23.3642.</citation>
    <PMID>23801867</PMID>
  </reference>
  <reference>
    <citation>Deguchi Y, Fukagawa T, Morita S, Ohashi M, Saka M, Katai H. Identification of risk factors for esophagojejunal anastomotic leakage after gastric surgery. World J Surg. 2012 Jul;36(7):1617-22. doi: 10.1007/s00268-012-1559-3.</citation>
    <PMID>22415758</PMID>
  </reference>
  <reference>
    <citation>Schietroma M, Cecilia EM, Carlei F, Sista F, De Santis G, Piccione F, Amicucci G. Prevention of anastomotic leakage after total gastrectomy with perioperative supplemental oxygen administration: a prospective randomized, double-blind, controlled, single-center trial. Ann Surg Oncol. 2013 May;20(5):1584-90. doi: 10.1245/s10434-012-2714-7. Epub 2012 Oct 26.</citation>
    <PMID>23099730</PMID>
  </reference>
  <reference>
    <citation>Kucukay F, Okten RS, Parlak E, Disibeyaz S, Ozogul Y, Bostanci EB, Olcer T. Self-expanding covered metallic stent treatment of esophagojejunostomy fistulas. Abdom Imaging. 2013 Apr;38(2):244-8. doi: 10.1007/s00261-012-9895-1.</citation>
    <PMID>22527158</PMID>
  </reference>
  <reference>
    <citation>Lang H, Piso P, Stukenborg C, Raab R, Jähne J. Management and results of proximal anastomotic leaks in a series of 1114 total gastrectomies for gastric carcinoma. Eur J Surg Oncol. 2000 Mar;26(2):168-71.</citation>
    <PMID>10744938</PMID>
  </reference>
  <reference>
    <citation>Langer FB, Wenzl E, Prager G, Salat A, Miholic J, Mang T, Zacherl J. Management of postoperative esophageal leaks with the Polyflex self-expanding covered plastic stent. Ann Thorac Surg. 2005 Feb;79(2):398-403; discussion 404.</citation>
    <PMID>15680802</PMID>
  </reference>
  <reference>
    <citation>Bardram L, Funch-Jensen P, Jensen P, Crawford ME, Kehlet H. Recovery after laparoscopic colonic surgery with epidural analgesia, and early oral nutrition and mobilisation. Lancet. 1995 Mar 25;345(8952):763-4.</citation>
    <PMID>7891489</PMID>
  </reference>
  <reference>
    <citation>Wilmore DW, Kehlet H. Management of patients in fast track surgery. BMJ. 2001 Feb 24;322(7284):473-6. Review.</citation>
    <PMID>11222424</PMID>
  </reference>
  <reference>
    <citation>Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg. 2002 Jun;183(6):630-41. Review.</citation>
    <PMID>12095591</PMID>
  </reference>
  <reference>
    <citation>Kehlet H. Future perspectives and research initiatives in fast-track surgery. Langenbecks Arch Surg. 2006 Sep;391(5):495-8. Epub 2006 Aug 19. Review.</citation>
    <PMID>16924532</PMID>
  </reference>
  <reference>
    <citation>Kehlet H, Wilmore DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg. 2008 Aug;248(2):189-98. doi: 10.1097/SLA.0b013e31817f2c1a. Review.</citation>
    <PMID>18650627</PMID>
  </reference>
  <reference>
    <citation>Wind J, Polle SW, Fung Kon Jin PH, Dejong CH, von Meyenfeldt MF, Ubbink DT, Gouma DJ, Bemelman WA; Laparoscopy and/or Fast Track Multimodal Management Versus Standard Care (LAFA) Study Group; Enhanced Recovery after Surgery (ERAS) Group. Systematic review of enhanced recovery programmes in colonic surgery. Br J Surg. 2006 Jul;93(7):800-9. Review.</citation>
    <PMID>16775831</PMID>
  </reference>
  <reference>
    <citation>Varadhan KK, Neal KR, Dejong CH, Fearon KC, Ljungqvist O, Lobo DN. The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials. Clin Nutr. 2010 Aug;29(4):434-40. doi: 10.1016/j.clnu.2010.01.004. Epub 2010 Jan 29.</citation>
    <PMID>20116145</PMID>
  </reference>
  <reference>
    <citation>Kehlet H, Slim K. The future of fast-track surgery. Br J Surg. 2012 Aug;99(8):1025-6. doi: 10.1002/bjs.8832. Epub 2012 Jun 14.</citation>
    <PMID>22696149</PMID>
  </reference>
  <reference>
    <citation>Olsén MF, Wennberg E. Fast-track concepts in major open upper abdominal and thoracoabdominal surgery: a review. World J Surg. 2011 Dec;35(12):2586-93. doi: 10.1007/s00268-011-1241-1. Review.</citation>
    <PMID>21882022</PMID>
  </reference>
  <reference>
    <citation>Lassen K, Kjaeve J, Fetveit T, Tranø G, Sigurdsson HK, Horn A, Revhaug A. Allowing normal food at will after major upper gastrointestinal surgery does not increase morbidity: a randomized multicenter trial. Ann Surg. 2008 May;247(5):721-9. doi: 10.1097/SLA.0b013e31815cca68.</citation>
    <PMID>18438106</PMID>
  </reference>
  <reference>
    <citation>Hur H, Si Y, Kang WK, Kim W, Jeon HM. Effects of early oral feeding on surgical outcomes and recovery after curative surgery for gastric cancer: pilot study results. World J Surg. 2009 Jul;33(7):1454-8. doi: 10.1007/s00268-009-0009-3.</citation>
    <PMID>19399550</PMID>
  </reference>
  <reference>
    <citation>Lewis SJ, Andersen HK, Thomas S. Early enteral nutrition within 24 h of intestinal surgery versus later commencement of feeding: a systematic review and meta-analysis. J Gastrointest Surg. 2009 Mar;13(3):569-75. doi: 10.1007/s11605-008-0592-x. Epub 2008 Jul 16. Review.</citation>
    <PMID>18629592</PMID>
  </reference>
  <reference>
    <citation>Liu XX, Jiang ZW, Wang ZM, Li JS. Multimodal optimization of surgical care shows beneficial outcome in gastrectomy surgery. JPEN J Parenter Enteral Nutr. 2010 May-Jun;34(3):313-21. doi: 10.1177/0148607110362583.</citation>
    <PMID>20467014</PMID>
  </reference>
  <reference>
    <citation>Wang D, Kong Y, Zhong B, Zhou X, Zhou Y. Fast-track surgery improves postoperative recovery in patients with gastric cancer: a randomized comparison with conventional postoperative care. J Gastrointest Surg. 2010 Apr;14(4):620-7. doi: 10.1007/s11605-009-1139-5. Epub 2010 Jan 28.</citation>
    <PMID>20108171</PMID>
  </reference>
  <reference>
    <citation>Chen Hu J, Xin Jiang L, Cai L, Tao Zheng H, Yuan Hu S, Bing Chen H, Chang Wu G, Fei Zhang Y, Chuan Lv Z. Preliminary experience of fast-track surgery combined with laparoscopy-assisted radical distal gastrectomy for gastric cancer. J Gastrointest Surg. 2012 Oct;16(10):1830-9. Epub 2012 Aug 2.</citation>
    <PMID>22854954</PMID>
  </reference>
  <reference>
    <citation>Kim JW, Kim WS, Cheong JH, Hyung WJ, Choi SH, Noh SH. Safety and efficacy of fast-track surgery in laparoscopic distal gastrectomy for gastric cancer: a randomized clinical trial. World J Surg. 2012 Dec;36(12):2879-87. doi: 10.1007/s00268-012-1741-7.</citation>
    <PMID>22941233</PMID>
  </reference>
  <reference>
    <citation>Fujitani K, Tsujinaka T, Fujita J, Miyashiro I, Imamura H, Kimura Y, Kobayashi K, Kurokawa Y, Shimokawa T, Furukawa H; Osaka Gastrointestinal Cancer Chemotherapy Study Group. Prospective randomized trial of preoperative enteral immunonutrition followed by elective total gastrectomy for gastric cancer. Br J Surg. 2012 May;99(5):621-9. doi: 10.1002/bjs.8706. Epub 2012 Feb 24.</citation>
    <PMID>22367794</PMID>
  </reference>
  <reference>
    <citation>Marano L, Porfidia R, Pezzella M, Grassia M, Petrillo M, Esposito G, Braccio B, Gallo P, Boccardi V, Cosenza A, Izzo G, Di Martino N. Clinical and immunological impact of early postoperative enteral immunonutrition after total gastrectomy in gastric cancer patients: a prospective randomized study. Ann Surg Oncol. 2013 Nov;20(12):3912-8. doi: 10.1245/s10434-013-3088-1. Epub 2013 Jul 10.</citation>
    <PMID>23838912</PMID>
  </reference>
  <reference>
    <citation>Braga M, Gianotti L, Vignali A, Di Carlo V. Immunonutrition in gastric cancer surgical patients. Nutrition. 1998 Nov-Dec;14(11-12):831-5.</citation>
    <PMID>9834924</PMID>
  </reference>
  <reference>
    <citation>Mabvuure NT, Roman A, Khan OA. Enteral immunonutrition versus standard enteral nutrition for patients undergoing oesophagogastric resection for cancer. Int J Surg. 2013;11(2):122-7. doi: 10.1016/j.ijsu.2012.12.012. Epub 2012 Dec 26. Review. Erratum in: Int J Surg. 2014;12(5):549. Roman, Ina [corrected to Roman, Alexandrina].</citation>
    <PMID>23274278</PMID>
  </reference>
  <reference>
    <citation>Mortensen K, Nilsson M, Slim K, Schäfer M, Mariette C, Braga M, Carli F, Demartines N, Griffin SM, Lassen K; Enhanced Recovery After Surgery (ERAS®) Group. Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Br J Surg. 2014 Sep;101(10):1209-29. doi: 10.1002/bjs.9582. Epub 2014 Jul 21.</citation>
    <PMID>25047143</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2017</study_first_submitted>
  <study_first_submitted_qc>August 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2017</study_first_posted>
  <last_update_submitted>August 21, 2017</last_update_submitted>
  <last_update_submitted_qc>August 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitari de Bellvitge</investigator_affiliation>
    <investigator_full_name>Leandre Farran Teixidor</investigator_full_name>
    <investigator_title>Chief of oesophagogastric surgery department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

